Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

We must disrupt harm

Julie Craig, MD
Meds
August 6, 2022
Share
Tweet
Share

In the mid-1980s, with the AIDS epidemic on the horizon, austere conservative Margaret Thatcher sanctioned the first needle exchanges in the U.K. to prevent the budgetary burden that HIV might otherwise have become on the National Health Service. Nearly forty years later, New York City opened its first supervised injection sites in November of 2021, where intravenous drug users inject their substances of choice under the watchful eye of staff bearing clean needles and Narcan – a triumph of harm reduction long fought and barely won in the United States.

Understanding harm reduction means separating the intrinsic versus extrinsic dangers that drugs may carry: fentanyl’s innately high binding affinity for the mu-opioid receptor confers an intrinsic risk of respiratory depression and fatal overdose. Contrarily, unknowingly consuming fentanyl-contaminated methamphetamines is an extrinsic hazard conferred by a wildly unregulated market that precludes standards for manufacturing and labeling. Moreover, high extrinsic risks often masquerade as intrinsic risks: fentanyl’s appearance in the American illicit market results directly from drug prohibition, which predictably favors stronger, denser products that are easier to smuggle by volume then dilute for distribution. Thus the fentanyl overdose crisis is less about fentanyl’s intrinsic properties than the milieu of prohibition that has resulted in drugs becoming predictably more potent over time.

At its most superficial level, harm reduction offers emergency bandaids on a range of risks: naloxone against opioid-driven respiratory suppression and clean syringes to prevent the spread of bloodborne pathogens. The radical Harm Reduction Coalition invokes deeper questions of justice and equity in social concerns that intersect with harm reduction: housing access, rights of sex workers, racial inequality in policing, and a number of other issues.

Putting all this together, your average Department of Health-led Narcan giveaway offers practical aid for immediate overdose crises but hardly alludes to (and may even oppose) disrupting the process of harm itself; the policies, laws, and socio-cultural norms that create extrinsic harms in the first place. Harm reduction asks, for example, that we provide clean needles and fentanyl test strips to reduce overdose and bloodborne infection. But disrupting the source of harm means challenging the extrinsic threat of incarceration that drives needle sharing and contaminated drug supplies at a time of historically unprecedented pharmaceutical technology.

Harm reduction favors law enforcement-assisted diversion (LEAD), drug courts, and drug treatment over incarceration. Disrupting harm requires that we interrogate the classification of drug use as a crime in the first place and question whether coerced treatment is just or effective when inflicted with the threat of incarceration. Harm disruption further demands that drug users’ rights to autonomy and self-determination inform the policies that affect their lives.

Harm reduction passes out clean syringes, often in underfunded, marginalized facilities. Harm disruption asks why the notoriously conservative Thatcher government-funded needle exchange as a cost-saving measure, but how cost shifting in a profit-driven health care market (such as the shift from private insurance to Medicare when a person becomes disabled by HIV/AIDS) annihilates incentives for evidence-based prevention strategies in the United States’ privatized health care sector.

Harm reduction offers critical services to marginalized individuals. Harm disruption requires an accounting of the global disaster that the drug industry and the war against it has inflicted on hotspots like Mexico and the emerging narco-state in Afghanistan since the fall of Kabul’s civilian government in 2021.

Harm reduction offers a razor margin of individual safety during drug use, often with the overarching goal of eventual abstinence-based recovery. Harm disruption acknowledges the ineluctable role that drugs like psychedelics, analgesics, and stimulants play in the plasticity-driven environment of the human brain, recognizing that a drug-free world would be a world bereft of some of humanity’s greatest artists, writers, musicians, inventors, and thinkers.

Harm reduction rings revolutionary with its origins in for-us/by-us spaces formed from the raw earth of mutual aid and autonomy among the most marginalized people. That subversive spirit deflates when the label is co-opted by well-meaning law enforcement agencies who proudly hand out Narcan while continuing to execute arrests under drug-war mandates. In that setting, harm reduction can be ultimately reductive, reducing individual misery and harm from drug prohibition to the tax-payer price of ER bills, HIV care, and incarceration. A harm disruption framework creates a discrete arena for policy wonks, health care equity advocates, economists, and families of overdose victims to address the policies and social norms that drive extrinsic harm without invading the critical space for people who use drugs to care for each other.

Thatcher’s initiatives have never come full circle, leaving the promise of fully integrating people who use drugs into all facets of society unfulfilled. A harm disruption framework that goes to the heart and root of drug-related harms can breathe new fire into the revolutionary spirit that underlies harm reduction and bring new life to the old Hippocratic adage:

First, we were told to do no harm.

First, now, we must disrupt harm.

Julie Craig is an addiction medicine specialist.

Image credit: Shutterstock.com

Prev

As we live in fear, there is still hope

August 6, 2022 Kevin 0
…
Next

Less resiliency may heal burnout [PODCAST]

August 6, 2022 Kevin 0
…

Tagged as: Pain Management

Post navigation

< Previous Post
As we live in fear, there is still hope
Next Post >
Less resiliency may heal burnout [PODCAST]

More by Julie Craig, MD

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The promises and limits of a fentanyl vaccine

    Julie Craig, MD
  • Allow patients to continue their opioid of choice while starting microdoses of buprenorphine

    Julie Craig, MD

Related Posts

  • Why social media may be causing real emotional harm

    Edwin Leap, MD
  • HIV/AIDS vaccine underscores need for better health access

    Alyson O’Daniel, PhD
  • Making America great again with harm reduction

    Mark Leeds, DO
  • People who take opioids are the AIDS patients of today

    Heather Finlay-Morreale, MD
  • Don’t let fear harm your health

    Michele Luckenbaugh
  • Protect and serve. Do no harm. Both are failing.

    Jayshree Chander, MD, MPH

More in Meds

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance
    • The heart of a Desi doctor: Balancing emotions and resources in oncology

      Dr. Damane Zehra | Physician
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Journal Shows Its Commitment to Exploring AI in Medicine
  • Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge
  • Cluster Headache, Migraine Linked to Circadian System
  • Smaller Liver Transplant Candidates Wait Longer, Less Likely to Receive Organ
  • A 'Double Whammy' for Gastric Cancer Risk

Meeting Coverage

  • Oral Roflumilast Effective in the Treatment of Plaque Psoriasis
  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Less Abuse With Extended-Release Oxycodone, Poison Center Data Suggest
  • Novel Strategies Show Winning Potential in Ovarian Cancer
  • Most Popular

  • Past Week

    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • Breaking free from a toxic relationship with medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Tom Brady’s legacy and the importance of personal integrity in end-of-life choices

      Kevin Haselhorst, MD | Physician
    • The hidden truths of hospital life: What doctors wish you knew

      Emily Stanford, DO | Physician
    • 10 commandments of ethical affiliate marketing for physicians

      Aaron Morgenstein, MD & Amy Bissada, DO | Finance
    • The heart of a Desi doctor: Balancing emotions and resources in oncology

      Dr. Damane Zehra | Physician
    • Safe sex for seniors: Dispelling myths and embracing safe practices [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...